Management Agreements in the Pharmaceuticals Industry

101 Contracts & Agreements

Browse by Company

Acacia Diversified Holdings, Inc. (1 contract)
Amneal Pharmaceuticals, Inc. (2)
APRICUS BIOSCIENCES, INC. (1)
Assertio Holdings, Inc. (2)
Assertio Therapeutics, Inc (11)
AVENUE THERAPEUTICS, INC. (1)
Big Rock Partners Acquisition Corp. (2)
BioPharmX Corp (1)
BODY & MIND INC. (3)
Catalent Inc (1)
CHINA PEDIATRIC PHARMACEUTICALS, INC. (1)
China Pharmaceuticals Inc (1)
CinCor Pharma, Inc. (1)
Clearside Biomedical, Inc. (1)
CLS Holdings USA, Inc. (1)
Cronos Group Inc. (1)
Exactus, Inc. (2)
GB SCIENCES INC (3)
HARROW HEALTH, INC. (1)
Haymaker Acquisition Corp. III (3)
Innoviva, Inc. (1)
Jaguar Health, Inc. (1)
Lexaria Bioscience Corp. (14)
Liquidia Corp (1)
Marijuana Co of America, Inc. (1)
MedMen Enterprises, Inc. (1)
Melt Pharmaceuticals, Inc. (1)
MICROCHANNEL TECHNOLOGIES CORP (1)
MJ Holdings, Inc. (3)
MYnd Analytics, Inc. (2)
Notis Global, Inc. (2)
OncoMed Pharmaceuticals Inc (3)
Osmotica Pharmaceuticals plc (1)
Paratek Pharmaceuticals, Inc. (1)
Perrigo (2)
Phathom Pharmaceuticals, Inc. (1)
PLAYERS NETWORK (1)
Prestige Brands Holdings Inc (1)
Rani Therapeutics Holdings, Inc. (1)
Raphael Pharmaceutical Inc. (1)
resTORbio, Inc. (1)
Royalty Pharma plc (9)
Scopus BioPharma Inc. (2)
SUNWIN STEVIA INTERNATIONAL, INC. (1)
Tenzing Acquisition Corp. (2)
Terra Tech Corp. (1)
TherapeuticsMD, Inc. (3)
Theravance Biopharma, Inc. (1)
United Cannabis Corp (1)

Recent Contracts

Assignment Agreement dated as of December 15, 2023 by and between Omaha Management Services, LLC, MME Retails Managements, LLC and Retail Facilities Operations AZ, LLC (MedMen Enterprises, Inc., Filed With SEC on January 12, 2024)
Letter Agreement, dated December 22, 2023, by and among Clearside Royalty LLC, Healthcare Royalty Partners IV, L.P. and HCR Clearside SPV, LLC (as assignee of HCR Collateral... (Clearside Biomedical, Inc., Filed With SEC on December 28, 2023)
Cooperation Agreement, dated as of December 21, 2023, by and among Theravance Biopharma, Inc., a Cayman Islands exempted company, Irenic Capital Management LP, a Delaware limited... (Theravance Biopharma, Inc., Filed With SEC on December 21, 2023)
Letter Agreement, dated September 21, 2023, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC (APRICUS BIOSCIENCES, INC., Filed With SEC on September 25, 2023)
Cooperation Agreement, dated as of August 28, 2023, by and among Elliott Investment Management L.P., a Delaware limited partnership, Elliott Associates, L.P., a Delaware limited... (Catalent Inc, Filed With SEC on August 29, 2023)
Form of Voting Agreement to be entered into between Parent and the Management Stockholders (Paratek Pharmaceuticals, Inc., Filed With SEC on June 7, 2023)
Management Agreement between the Company and MJ Distributing, Inc (MJ Holdings, Inc., Filed With SEC on May 23, 2023)
First Amendment to Revenue Interest Financing Agreement, dated as of April 17, 2023, by and among Liquidia Technologies, Inc., Healthcare Royalty Partners IV, L.P., and HCR... (Liquidia Corp, Filed With SEC on May 8, 2023)
Management Services Agreement between Big Bhang Events, LLC and NMG MI 1, Inc., dated April 14, 2023 (BODY & MIND INC., Filed With SEC on April 19, 2023)
Second Amended and Restated Management and Services Agreement dated October 3, 2022, among Royalty Pharma Investments 2019 ICAV and RP Management, LLC (Royalty Pharma plc, Filed With SEC on November 8, 2022)
Amended and Restated Management and Services Agreement dated October 3, 2022, among Royalty Pharma Holdings Limited and RP Management, LLC (Royalty Pharma plc, Filed With SEC on November 8, 2022)
Amended and Restated Management and Services Agreement dated October 3, 2022, among the Company and RP Management, LLC (Royalty Pharma plc, Filed With SEC on November 8, 2022)
Subscription Agreement between TherapeuticsMD, Inc. and Rubric Capital Management LP, dated October 28, 2022 (TherapeuticsMD, Inc., Filed With SEC on October 31, 2022)
Subscription Agreement between TherapeuticsMD, Inc. and Rubric Capital Management LP, dated September 30, 2022 (TherapeuticsMD, Inc., Filed With SEC on October 3, 2022)
Management Services Agreement, dated February 1, 2019, by and between the Registrant an Harrow Health, Inc (Melt Pharmaceuticals, Inc., Filed With SEC on September 21, 2022)
Revenue Interest Financing Agreement, dated May 3, 2022, by and among NovaQuest Capital Management, Sagard Holding Manager, Hercules Capital and the Registrant (Phathom Pharmaceuticals, Inc., Filed With SEC on August 2, 2022)
Subscription Agreement between TherapeuticsMD, Inc. and Rubric Capital Management LP, dated July 29, 2022 (TherapeuticsMD, Inc., Filed With SEC on August 1, 2022)
Management and Operations Agreement, dated as of July 5, 2022, between Sheffa Enterprises Inc. and the Company (Raphael Pharmaceutical Inc., Filed With SEC on July 7, 2022)
Form of Management Continuity Agreement (Assertio Holdings, Inc., Filed With SEC on March 10, 2022)
Management Services Agreement dated Dec. 31, 2021 with C.A.B. Financial Services Ltd. (Chris Bunka) (Lexaria Bioscience Corp., Filed With SEC on January 14, 2022)
Amended and Restated Management Services Agreement, dated as of April 16, 2020, by and between the Registrant and CinRx Pharma, LLC (CinCor Pharma, Inc., Filed With SEC on December 17, 2021)
Business Combination Agreement, dated as of December 13, 2021, by and among the Company, Haymaker Sponsor III LLC, BioTe Holdings, LLC, BioTe Management, LLC, Dr. Gary Donovitz,... (Haymaker Acquisition Corp. III, Filed With SEC on December 14, 2021)
Management Services Agreement dated October 20, 2021, by and among Kealii Okamalu, LLC, CSI Health MCD LLC, and the Fort McDermitt Cannabis Commission (CLS Holdings USA, Inc., Filed With SEC on October 26, 2021)
Management Services Agreement: Salinas Diversified Ventures, Inc. & VBF Brands, Inc., Sunset Island Group, Inc (Marijuana Co of America, Inc., Filed With SEC on October 13, 2021)
Service Agreement, by and between Rani Management Services, Inc. and InCube Labs, LLC, dated January 1, 2021 (Rani Therapeutics Holdings, Inc., Filed With SEC on July 9, 2021)
Management Services Agreement between Registrant, 483 Management, LLC, and GB Sciences Nopah, LLC dated August 10, 2020 (GB SCIENCES INC, Filed With SEC on July 6, 2021)
Amendment No. 1, dated as of November 20, 2020, to the Shareholders Agreement, dated as of October 17, 2018, by and among, Osmotica Pharmaceuticals plc, ACP Holdco (Offshore),... (Osmotica Pharmaceuticals plc, Filed With SEC on March 30, 2021)
Administrative Support Agreement, dated March 1, 2021, by and between the Company and Mistral Capital Management LLC (Haymaker Acquisition Corp. III, Filed With SEC on March 5, 2021)
Form of Administrative Services Agreement between the Registrant and Mistral Capital Management LLC (Haymaker Acquisition Corp. III, Filed With SEC on February 22, 2021)
Strategic Advisory Agreement, dated as of December 11, 2020, by and between Sarissa Capital Management LP and Innoviva, Inc (Innoviva, Inc., Filed With SEC on December 14, 2020)
Amended and Restated Management and Services Agreement dated June 11, 2020, among Royalty Pharma Investments 2019 ICAV and RP Management, LLC (Royalty Pharma plc, Filed With SEC on October 13, 2020)
Management and Services Agreement dated June 15, 2020, among the Company and RP Management, LLC (Royalty Pharma plc, Filed With SEC on October 13, 2020)
Management Services Agreement by and among Registrant, GB Sciences Nevada, LLC, GB Sciences Las Vegas, LLC, and AJE Management, LLC dated December 6, 2020 (GB SCIENCES INC, Filed With SEC on August 28, 2020)
Form of Management Continuity Agreement, dated June 23, 2020, between Zyla Life Sciences and Zyla Life Sciences executive officers (Assertio Holdings, Inc., Filed With SEC on August 10, 2020)
Management Agreement (MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on July 24, 2020)
Amended and Restated Management and Services Agreement dated June 11, 2020, among Royalty Pharma Investments 2019 ICAV and RP Management, LLC (Royalty Pharma plc, Filed With SEC on June 19, 2020)
Management and Services Agreement dated June 15, 2020, among the Company and RP Management, LLC (Royalty Pharma plc, Filed With SEC on June 19, 2020)
Management Services Agreement dated June 1, 2017 with M&E Services Ltd. (Spissinger) (Lexaria Bioscience Corp., Filed With SEC on June 3, 2020)
Management Services Agreement dated June 19, 2017 with Dr. Phil Ainslie (Lexaria Bioscience Corp., Filed With SEC on June 3, 2020)
Form of Amended and Restated Management and Services Agreement, dated, 2020, among Royalty Pharma Investments 2019 ICAV and RP Management, LLC (Royalty Pharma plc, Filed With SEC on May 22, 2020)